Antibodies
US11261254B1 · kind B1 · utility
0Cited by
16References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 2021 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | Oct 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies binding to B7H4, including bispecific antibodies binding to B7H4 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.